News
23h
MedPage Today on MSNPhototherapy Promising as Add-On to Oral Ritlecitinib for VitiligoAdding narrowband ultraviolet B (UVB) phototherapy to oral treatment with ritlecitinib (Litfulo) enhanced repigmentation in ...
Pfizer has encountered many setbacks in its quest to launch a medicine that could rival Wegovy and Zepbound. One of its ...
11h
24/7 Wall St. on MSNIf You Like Schwab's SCHD, You Can't Miss These Stocks With Even Higher YieldsThe Schwab U.S. Dividend Equity ETF (NYSEARCA:SCHD) has a reputation for being the go-to choice for income-focused investors ...
Drug manufacturer Eli Lilly announced this week that an encouraging clinical trial of their new pill promises a convenient, ...
As tough as it may be to do right now, this is a great time to hold your nose and dive in while yields are as high as they are.
11h
Verywell Health on MSNDaily GLP-1 Pill Shows Promise for Diabetes and Weight Loss, Eli Lilly SaysA new drug, called orforglipron, can help people with diabetes manage their A1C and weight, according to topline results from ...
Advancements in mRNA vaccine technology are reshaping medicine, addressing challenges and expanding applications from ...
The pharmaceutical industry faces environmental challenges. Green chemistry offers sustainable solutions to reduce waste and enhance drug discovery processes.
15h
inews.co.uk on MSNWho could take new weight-loss pill – and who should avoid itThe first daily weight-loss pill is expected to be available in the UK as soon as 2026 after a trial found it to be effective ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results